Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients

Anticancer Research

Volumn 30, Issue 1, 2010, Pages 245-252

  Jin, Yonghui ^a   Shima, Yasuko ^a,b   Furu, Moritoshi ^a,b   Aoyama, Tomoki ^b   Nakamata, Takeharu ^b   Nakayama, Tomitaka ^b   Nakamura, Takashi ^b   Toguchida, Junya ^a,b,c  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Japan; Mutation; RAS; Soft tissue sarcoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RAS; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SARCOMA; YOUNG ADULT;

EID: 77649254901     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barbacid M: Ras genes. Annu Rev Biochem 56: 779-827, 1987.
2. Bos JL: The ras gene family and human carcinogenesis. Mutat Res 195: 255-271, 1988.
3. Land H, Parada LF and Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-602, 1983.
4. Yancopoulos GD, Nisen PD, Tesfaye A, Kohl NE, Goldfarb MP and Alt FW: N-myc can cooperate with ras to transform normal cells in culture. Proc Natl Acad Sci USA 82: 5455-5459, 1985.
5. Shima Y, Okamoto T, Aoyama T, Yasura K, Ishibe T, Nishijo K, Shibata KR, Kohno Y, Fukiage K, Otsuka S, Uejima D, Nakayama T, Nakamura T, Kiyono T and Toguchida J: In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12. Biochem Biophys Res Commun 353: 60-66, 2007.
6. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989.
7. Cooper CS and Stratton MR: Soft tissue tumours: the genetic basis of development. Carcinogenesis 12: 155-165, 1991.
8. Enzinger FM and Weiss SW: Soft Tissue Tumors, Third ed., Mosby, St.Louis, MO, 1995.
9. Stratton MR, Fisher C, Gusterson BA and Cooper CS: Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res 49: 6324-6327, 1989.
10. Bohle RM, Brettreich S, Repp R, Borkhardt A, Kosmehl H and Altmannsberger HM: Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas. Am J Pathol 148: 731-738, 1996.
11. Hill MA, Gong C, Casey TJ, Menon AG, Mera R, Gillespie AT, Giardina JF, Levine EA and Hunt JD: Detection of K-ras mutations in resected primary leiomyosarcoma. Cancer Epidemiol Biomarkers Prev 6: 1095-1100, 1997.
12. Rieske P, Bartkowiak J, Szadowska A and Debiec-Rychter M: Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations. Mol Pathol 52: 64-67, 1999.
13. Yoo J, Robinson RA and Lee JY: H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes. Mod Pathol 12: 775-780, 1999.
14. Yoo J and Robinson RA: H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients. Cancer 86: 58-63, 1999.
15. Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y and Tsuneyoshi M: Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Mod Pathol 13: 994-1004, 2000.
16. Barrios C, Castresana JS, Ruiz J and Kreicbergs A: Amplification of the c-myc proto-oncogene in soft tissue sarcomas. Oncology 51: 13-17, 1994.
17. Takahashi Y, Oda Y, Kawaguchi K, Tamiya S, Yamamoto H, Suita S and Tsuneyoshi M: Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Mod Pathol 17: 660-669, 2004.
18. Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T and Toguchida J: Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11: 2702-2712, 2005.
19. Sonobe H, Manabe Y, Furihata M, Iwata J, Oka T, Ohtsuki Y, Mizobuchi H, Yamamoto H, Kumano O and Abe S: Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II. Lab Invest 67: 498-505, 1992.
20. Kawai A, Naito N, Yoshida A, Morimoto Y, Ouchida M, Shimizu K and Beppu Y: Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett 204: 105-113, 2004.
21. Nojima T, Wang YS, Abe S, Matsuno T, Yamawaki S and Nagashima K: Morphological and cytogenetic studies of a human synovial sarcoma xenotransplanted into nude mice. Acta Pathol Jpn 40: 486-493, 1990.
22. Imaizumi S, Motoyama T, Ogose A, Hotta T and Takahashi HE: Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1. Virchows Arch 433: 435-441, 1998.
23. Hosoi H, Sugimoto T, Hayashi Y, Inaba T, Horii Y, Morioka H, Fushiki S, Hamazaki M and Sawada T: Differential expression of myogenic regulatory genes, MyoD1 and myogenin, in human rhabdomyosarcoma sublines. Int J Cancer 50: 977-983, 1992.
24. Sambrook J, Molecular Cloning: A Laboratory Manual (Third ed.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001.
25. Suzuki Y, Orita M, Shiraishi M, Hayashi K and Sekiya T: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5: 1037-1043, 1990.
26. Orita M, Suzuki Y, Sekiya T and Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879, 1989.
27. Aoyama T, Nagayama S, Okamoto T, Hosaka T, Nakamata T, Nishijo K, Tsuboyama T, Nakayama T, Nakamura T and Toguchida J: Mutation analyses of the NFAT1 gene in chondrosarcomas and enchondromas. Cancer Lett 186: 49-57, 2002.
28. Hayashi K: PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1: 34-38, 1991.
29. Toguchida J and Nakayama T: Molecular genetics of sarcomas: Applications to diagnoses and therapy. Cancer Sci 100: 1573-1580, 2009.
30. Ladanyi M: Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 20: 5755-5762, 2001.
31. Fletcher JA and Rubin BP: KIT mutations in GIST. Curr Opin Genet Dev 17: 3-7, 2007.
32. Sabah M, Cummins R, Leader M and Kay E: Aberrant expression of the Rb pathway proteins in soft tissue sarcomas. Appl Immunohistochem Mol Morphol 14: 397-403, 2006.
33. Taubert, H Meye A and Wurl P: Soft tissue sarcomas and p53 mutations. Mol Med 4: 365-372, 1998.
34. Hestekin CN and Barron AE: The potential of electrophoretic mobility shift assays for clinical mutation detection. Electrophoresis 27: 3805-3815, 2006.
35. Scarpa A, Capelli P, Villaneuva A, Zamboni G, Lluis F, Accolla R, Mariuzzi G and Capella G: Pancreatic cancer in Europe: Ki-ras gene mutation pattern shows geographical differences. Int J Cancer 57: 167-171, 1994.
36. Konishi N, Hiasa Y, Tsuzuki T, Tao M, Enomoto T and Miller GJ: Comparison of ras activation in prostate carcinoma in Japanese and American men. Prostate 30: 53-57, 1997.